Medical College receives grants for leukemia research, more

By BizTimes Staff

Oct 15, 2014 12:00 am

Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin.

The Medical College of Wisconsin has recently received several grants to study such topics as chronic myeloid leukemia, type 1 diabetes and more. Below is a rundown of the grants.

MCW received a five-year, $3.4 million grant from the National Institutes of Health’s National Cancer Institute to investigate the use of tyrosine kinase inhibitors in treating chronic myeloid leukemia, a type of cancer starting in the blood-forming cells of the bone marrow. It is estimated that about 6,000 cases of CML will emerge in the United States in 2014, resulting in 800 deaths.

A collaborative team of researchers from BloodCenter of Wisconsin and MCW has received a one-year, $50,000 grant from the Clinical and Translational Science Institute of Southeast Wisconsin to study the effects of platelet transfusion on newborns whose medical conditions require the procedure.

A collaborative team of researchers from MCW and the Milwaukee School of Engineering has received a one-year, $50,000 grant from the Clinical and Translational Science Institute of Southeast Wisconsin to study possible interventions to prevent the development of type 1 diabetes. T1D is a lifelong disease in which the insulin producing pancreatic beta cells are largely destroyed, disabling patients’ ability to regulate blood sugar.

MCW has received a five-year, $500,000 training grant from the National Institutes of Health’s National Institute of Environmental Health Sciences to investigate the development of a tool to interpret the genetic data of humans affected with cardiovascular disease. The tool will allow for an improved understanding of how to diagnose and treat cardiovascular disease.

MCW has received a four-year, $1.2 million grant from the National Institutes of Health’s National Institute of General Medical Sciences to advance the understanding of how endotoxin, a major component of disease-causing bacteria, is transported within the cell. Understanding the proteins and interactions involved in the transportation may give insights into how to combat potentially deadly disease-causing bacteria.

What's New

BizPeople

Submit a BizPeople

Share new hires, promotions and employee accolades with the region's business leaders.

Sponsored Content

The Medical College of Wisconsin has recently received several grants to study such topics as chronic myeloid leukemia, type 1 diabetes and more. Below is a rundown of the grants.

MCW received a five-year, $3.4 million grant from the National Institutes of Health’s National Cancer Institute to investigate the use of tyrosine kinase inhibitors in treating chronic myeloid leukemia, a type of cancer starting in the blood-forming cells of the bone marrow. It is estimated that about 6,000 cases of CML will emerge in the United States in 2014, resulting in 800 deaths.

A collaborative team of researchers from BloodCenter of Wisconsin and MCW has received a one-year, $50,000 grant from the Clinical and Translational Science Institute of Southeast Wisconsin to study the effects of platelet transfusion on newborns whose medical conditions require the procedure.

A collaborative team of researchers from MCW and the Milwaukee School of Engineering has received a one-year, $50,000 grant from the Clinical and Translational Science Institute of Southeast Wisconsin to study possible interventions to prevent the development of type 1 diabetes. T1D is a lifelong disease in which the insulin producing pancreatic beta cells are largely destroyed, disabling patients’ ability to regulate blood sugar.

MCW has received a five-year, $500,000 training grant from the National Institutes of Health’s National Institute of Environmental Health Sciences to investigate the development of a tool to interpret the genetic data of humans affected with cardiovascular disease. The tool will allow for an improved understanding of how to diagnose and treat cardiovascular disease.

MCW has received a four-year, $1.2 million grant from the National Institutes of Health’s National Institute of General Medical Sciences to advance the understanding of how endotoxin, a major component of disease-causing bacteria, is transported within the cell. Understanding the proteins and interactions involved in the transportation may give insights into how to combat potentially deadly disease-causing bacteria.